Artificial exosomes can be designed to encapsulate and deliver therapeutic payloads, including drugs, genes, and proteins.

Additional investors include global investment firm Viking Global Investors, charity foundation CureEB, the Epidermolysis ...

DelveInsight's " Aplastic Anemia Market Insights, Epidemiology, and Market Forecast- 2034" report delivers an in-depth ...

Tonix Pharmaceuticals has no tonic for cocaine intoxication, with the biopharma terminating a midstage trial for the ...

Biomay's recent achievement refers to an inspection by the FDA's Center for Biologics Evaluation and Research (CBER) at ...

As global markets navigate through trade uncertainties and economic shifts, the Asian tech sector remains a focal point for investors seeking growth opportunities. With smaller-cap indexes ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Abnormal kinase signaling can promote other harmful traits, such as neuroinflammation and neuronal cell death. On the other ...

A new clotbusting drug tested on mice has been shown by University of Manchester scientists to be significantly better at ...

YONGIN, South Korea, April 9, 2025 /PRNewswire/ -- GC Biopharma announced 09. Apr. 2025 that the Korean Ministry of Food and Drug Safety (MFDS) has approved its anthrax vaccine, BARYTHRAX, jointly ...

Capitalizing on the flexibility of tiny cells inside the body's smallest blood vessels may be a powerful spinal cord repair ...